IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

B Verstockt, A Salas, BE Sands, C Abraham… - Nature Reviews …, 2023 - nature.com
Abstract Interleukin-12 (IL-12) and interleukin-23 (IL-23), which belong to the IL-12 family of
cytokines, have a key role in intestinal homeostasis and inflammation and are implicated in …

[HTML][HTML] The expanding role of anti–IL-12 and/or anti–IL-23 antibodies in the treatment of inflammatory bowel disease

A Kashani, DA Schwartz - Gastroenterology & hepatology, 2019 - ncbi.nlm.nih.gov
Abstract The interleukin (IL)-12/IL-23 pathway is one of many proposed mechanistic
pathways of intestinal inflammation. Earlier studies introduced IL-12 as a major cytokine in …

Clinical trials of IL-12/IL-23 inhibitors in inflammatory bowel disease

A Almradi, J Hanzel, R Sedano, CE Parker, BG Feagan… - BioDrugs, 2020 - Springer
The inflammatory bowel diseases (IBDs) are chronic immune-mediated inflammatory
disorders, including ulcerative colitis (UC) and Crohn's disease (CD). IBD results from a …

Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention

GW Sewell, A Kaser - Journal of Crohn's and Colitis, 2022 - academic.oup.com
Abstract The interleukin-23 [IL-23] cytokine, derived predominantly from macrophages and
dendritic cells in response to microbial stimulation, has emerged as a critical promoter of …

[HTML][HTML] Differential roles for interleukin-23 and interleukin-17 in intestinal immunoregulation

JR Maxwell, Y Zhang, WA Brown, CL Smith, FR Byrne… - Immunity, 2015 - cell.com
Summary Interleukin-23 (IL-23) and IL-17 are cytokines currently being targeted in clinical
trials. Although inhibition of both of these cytokines is effective for treating psoriasis, IL-12 …

[HTML][HTML] Interleukin-12 and Th1 immune response in Crohn's disease: Pathogenetic relevance and therapeutic inplication

I Peluso, F Pallone, G Monteleone - World journal of …, 2006 - ncbi.nlm.nih.gov
Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory disorders of the
gastrointestinal tract that share clinical and pathological characteristics. The most accredited …

IL-23 in inflammatory bowel diseases and colon cancer

MF Neurath - Cytokine & growth factor reviews, 2019 - Elsevier
Studies in recent years have identified a pivotal role of the cytokine IL-23 in the
pathogenesis of inflammatory bowel diseases (IBD: Crohn´ s disease, ulcerative colitis) and …

Lessons learned from trials targeting cytokine pathways in patients with inflammatory bowel diseases

C Abraham, PS Dulai, S Vermeire, WJ Sandborn - Gastroenterology, 2017 - Elsevier
Insights into the pathogenesis of inflammatory bowel diseases (IBDs) have provided
important information for the development of therapeutics. Levels of interleukin 23 (IL23) and …

The IL-23/IL-17 pathway in inflammatory bowel disease

A Geremia, DP Jewell - Expert review of gastroenterology & …, 2012 - Taylor & Francis
The etiology of inflammatory bowel disease is unknown but available evidence suggests
that a deregulated immune response towards the commensal bacterial flora is responsible …

IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting

AR Moschen, H Tilg, T Raine - Nature Reviews Gastroenterology & …, 2019 - nature.com
Abstract IL-12 and IL-23 are closely related cytokines with important roles in the regulation of
tissue inflammation. Converging evidence from studies in mice, human observational …